The transcriptional repressor REV-ERB as a novel target for disease

Amaia Uriz-Huarte1, Amrita Date1, Heather Ang2

  • 1Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, UK.

Insights

Nuclear receptor REV-ERB regulates key physiological processes and is a potential drug target. Developing higher quality synthetic ligands is crucial for validating REV-ERB

Area of Science:

  • Molecular biology
  • Pharmacology
  • Endocrinology

Background:

  • REV-ERB, a nuclear receptor, influences circadian rhythms, immunity, and metabolism.
  • It presents a promising yet challenging target for therapeutic intervention in various diseases.

Purpose of the Study:

  • To review the function and regulation of REV-ERB.
  • To explore its role in human diseases.
  • To highlight the medicinal chemistry of synthetic REV-ERB ligands.

Main Methods:

  • Literature review of REV-ERB function, modulation, and disease involvement.
  • Focus on synthetic ligand medicinal chemistry and development.

Main Results:

  • REV-ERB's broad physiological roles are established.
  • Synthetic ligands show potential but require improvement.
  • Higher quality ligands are needed for target validation.

Conclusions:

  • REV-ERB is a significant target for drug development.
  • Advancements in synthetic ligand chemistry are essential for therapeutic success.
  • Further research is needed to fully exploit REV-ERB's potential.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K
Master Transcription Regulators02:23

Master Transcription Regulators

2.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.8K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.5K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.2K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K